Home/Filings/4/0001104659-21-001505
4//SEC Filing

Seiser Robert A 4

Accession 0001104659-21-001505

CIK 0000786947other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:11 PM ET

Size

12.2 KB

Accession

0001104659-21-001505

Insider Transaction Report

Form 4
Period: 2021-01-04
Seiser Robert A
VP, Controller & Treasurer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-01-04+24,667351,824 total
  • Exercise/Conversion

    Restricted Stock Unit (2017 Plan)

    2021-01-04+4,66764,666 total
    Exercise: $0.01Common Stock (4,667 underlying)
  • Tax Payment

    Common Stock

    2021-01-04$0.21/sh10,686$2,244341,138 total
  • Exercise/Conversion

    Restricted Stock Unit (2017 Plan)

    2021-01-04+20,00049,333 total
    Exercise: $0.01Common Stock (20,000 underlying)
Footnotes (7)
  • [F1]Represents exchange of restricted stock units.
  • [F2]Par value of $.01 must be paid by Reporting Person upon exchange of Restricted Stock Units for stock.
  • [F3]Does not include Restricted Stock Units.
  • [F4]Not Applicable.
  • [F5]14,000 Restricted Stock Units were granted on December 11, 2017 and were 100% vested on December 11, 2018. Distributions in respect of this vested Restricted Stock Units will be made in three equal installments on the first business day of each of January 2020, 2021, and 2022 or earlier upon a qualifying change of control which also meets certain criteria of Section 409A of the Internal Revenue Code.
  • [F6]Shares of common stock of the Issuer withheld by the Issuer in satisfaction of the Reporting Person's par value purchase price and tax withholdings on the exchange of 24,667 Restricted Stock Units for common stock of the Issuer.
  • [F7]60,000 Restricted Stock Units were granted on December 11, 2018 and were 100% vested on December 11, 2019. Distributions in respect of this vested Restricted Stock Units will be made in three equal installments on the first business day of each of January 2021, 2022, and 2023 or earlier upon a qualifying change of control which also meets certain criteria of Section 409A of the Internal Revenue Code.

Issuer

ACURA PHARMACEUTICALS, INC

CIK 0000786947

Entity typeother

Related Parties

1
  • filerCIK 0001416145

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:11 PM ET
Size
12.2 KB